Mascoma Wealth Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Mascoma Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-80	Closed	-$1K	–	418
2018 Q4	$1K	Hold	80	–	–	﹤0.01%	363
2018 Q3	$2K	Hold	80	–	–	﹤0.01%	369
2018 Q2	$2K	Hold	80	–	–	﹤0.01%	367
2018 Q1	$1K	Hold	80	–	–	﹤0.01%	365
2017 Q4	$2K	Sell	80 -87	-52%	-$1.31K	﹤0.01%	348
2017 Q3	$3K	Hold	167	–	–	﹤0.01%	352
2017 Q2	$6K	Sell	167 -200	-54%	-$6.19K	﹤0.01%	317
2017 Q1	$12K	Sell	367 -404	-52%	-$13.8K	0.01%	250
2016 Q4	$28K	Buy	+771	New	+$30.8K	0.02%	186

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Mascoma Wealth Management's TEVA Position: Q1 2019 in Review

Mascoma Wealth Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2019, closing a stake of 80 shares — an estimated $1K sold.

Mascoma Wealth Management first reported a position in TEVA in Q4 2016 and held it in 9 quarters. The position peaked at $28K in Q4 2016. 522 funds tracked by Wall St. Rank hold TEVA as of Q1 2019.

Mascoma Wealth Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2019 after selling out during the quarter.
Mascoma Wealth Management sold 80 Teva Pharmaceutical Industries Limited shares in Q1 2019, an estimated $1K.
Mascoma Wealth Management first reported a position in Teva Pharmaceutical Industries Limited in Q4 2016 and held it in 9 quarters.
Mascoma Wealth Management's Teva Pharmaceutical Industries Limited position peaked at $28K in Q4 2016.
522 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2019.

Based on Mascoma Wealth Management's 13F filing for Q1 2019, filed 23 Apr 2019.